Two-drug maintenance therapy keeps viral load suppressed and may even have advantages over traditional ART
Tenofovir alafenamide single-tablet regimen shows good efficacy with improved kidney and bone safety
Can dolutegravir dual therapy or monotherapy produce and maintain HIV suppression?
Rilpivirine + darunavir HIV maintenance regimen matches standard three-drug antiretroviral therapy
People with HIV and hepatitis B co-infection can safely switch to simpler TAF single-tablet regimen
Switching to new tenofovir alafenamide keeps virus in check and improves kidney and bone health
